» Articles » PMID: 11897817

Prevalence of SDHB, SDHC, and SDHD Germline Mutations in Clinic Patients with Head and Neck Paragangliomas

Overview
Journal J Med Genet
Specialty Genetics
Date 2002 Mar 19
PMID 11897817
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Paragangliomas are rare and highly heritable tumours of neuroectodermal origin that often develop in the head and neck region. Germline mutations in the mitochondrial complex II genes, SDHB, SDHC, and SDHD, cause hereditary paraganglioma (PGL).

Methods: We assessed the frequency of SDHB, SDHC, and SDHD gene mutations by PCR amplification and sequencing in a set of head and neck paraganglioma patients who were previously managed in two otolaryngology clinics in the USA.

Results: Fifty-five subjects were grouped into 10 families and 37 non-familial cases. Five of the non-familial cases had multiple tumours. Germline SDHD mutations were identified in five of 10 (50%) familial and two of 37 ( approximately 5%) non-familial cases. R38X, P81L, H102L, Q109X, and L128fsX134 mutations were identified in the familial cases and P81L was identified in the non-familial cases. Both non-familial cases had multiple tumours. P81L and R38X mutations have previously been reported in other PGL families and P81L was suggested as a founder mutation. Allelic analyses of different chromosomes carrying these mutations did not show common disease haplotypes, strongly suggesting that R38X and P81L are potentially recurrent mutations. Germline SDHB mutations were identified in two of 10 (20%) familial and one of 33 ( approximately 3%) non-familial cases. P131R and M71fsX80 were identified in the familial cases and Q59X was identified in the one non-familial case. The non-familial case had a solitary tumour. No mutations could be identified in the SDHC gene in the remaining four families and 20 sporadic cases.

Conclusions: Mutations in SDHD are the leading cause of head and neck paragangliomas in this clinic patient series. SDHD and SDHB mutations account for 70% of familial cases and approximately 8% of non-familial cases. These results also suggest that the commonness of the SDHD P81L mutation in North America is the result of both a founder effect and recurrent mutations.

Citing Articles

Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity.

Ortmann B BMJ Oncol. 2025; 3(1):e000154.

PMID: 39886164 PMC: 11203102. DOI: 10.1136/bmjonc-2023-000154.


Germline predisposition in multiple myeloma.

Rodrigues F, Jasielec J, Perpich M, Kim A, Moma L, Li Y iScience. 2025; 28(1):111620.

PMID: 39845416 PMC: 11750583. DOI: 10.1016/j.isci.2024.111620.


Multiple primary tumors in a patient with non‑small‑cell lung cancer harboring mutations in and : A case report.

Wu H, Jiang Y, He M, Xu X, Jiang H Oncol Lett. 2024; 29(1):63.

PMID: 39611066 PMC: 11602829. DOI: 10.3892/ol.2024.14809.


Thyroid Paraganglioma: A Rare Manifestation of Paraganglioma Syndrome Associated With Pathogenic Variant in .

Tarasova V, Samuel K, McMullen C, Kushchayev S, Hernandez Prera J, Veloski C JCEM Case Rep. 2024; 2(9):luae135.

PMID: 39156002 PMC: 11327117. DOI: 10.1210/jcemcr/luae135.


Comprehensive Investigation of Angiogenesis, PASS Score and Immunohistochemical Factors in Risk Assessment of Malignancy for Paraganglioma and Pheochromocytoma.

Milinkovic M, Soldatovic I, Zivaljevic V, Bozic V, Zivotic M, Tatic S Diagnostics (Basel). 2024; 14(8).

PMID: 38667494 PMC: 11049119. DOI: 10.3390/diagnostics14080849.


References
1.
Baysal B, Ferrell R, Willett-Brozick J, Lawrence E, Myssiorek D, Bosch A . Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000; 287(5454):848-51. DOI: 10.1126/science.287.5454.848. View

2.
Lack E . Hyperplasia of vagal and carotid body paraganglia in patients with chronic hypoxemia. Am J Pathol. 1978; 91(3):497-516. PMC: 2018321. View

3.
Niemann S, Muller U . Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet. 2000; 26(3):268-70. DOI: 10.1038/81551. View

4.
Gimm O, Armanios M, Dziema H, Neumann H, Eng C . Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. Cancer Res. 2001; 60(24):6822-5. View

5.
Baysal B, Willett-Brozick J, Taschner P, Dauwerse J, Devilee P, Devlin B . A high-resolution integrated map spanning the SDHD gene at 11q23: a 1.1-Mb BAC contig, a partial transcript map and 15 new repeat polymorphisms in a tumour-suppressor region. Eur J Hum Genet. 2001; 9(2):121-9. DOI: 10.1038/sj.ejhg.5200585. View